Review of combination immunotherapies seen at ASCO 2016

June 22, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to review the Phase 1 data presented at ASCO 2016 for combination immuno and targeted therapies.

This entry was posted in - Biotech, - Pharma, Oncology, UCLA. Bookmark the permalink.

Leave a Reply

Your email address will not be published.